Last updated: July 20, 2023
Sponsor: Medical University of Silesia
Overall Status: Active - Recruiting
Phase
2/3
Condition
Corticobasal Degeneration
Muscle Pain
Dyskinesias
Treatment
5% polymer gel with CBD application
Placebo intervention
10% polymer gel with CBD application
Clinical Study ID
NCT05562635
CBD (Cannabidiol)
Ages 18-60 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient agreement to participate into the research study
- Age ≥18 and ≤ 60
- Good general health,
- Temporomandibular disorder-positive RDC/TMD examination for group Ia and Ib
- Presence of all teeth (with the exception of the third molars)
Exclusion
Exclusion Criteria:
- Cannabis cream/ placebo cream allergy
- Hypersensitivity to substances to be used in the study
- Wounds intra oral cavity
- Addiction to cannabis
- Patients being treated with analgesic drugs and/or drugs that affect muscle function
Study Design
Total Participants: 30
Treatment Group(s): 3
Primary Treatment: 5% polymer gel with CBD application
Phase: 2/3
Study Start date:
July 18, 2023
Estimated Completion Date:
August 30, 2023
Study Description
Connect with a study center
Department of TMD
Zabrze, 41-800
PolandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.